An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
About this item
Full title
Author / Creator
Zhou, Xin , Chen, Zhuo and Bi, Xinling
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Biologic drugs have revolutionized the treatment of psoriasis and other rheumatological diseases. In recent years, many biosimilar agents that are highly similar in structure and function to their originator products have been developed, including the tumor necrosis factor-alpha antagonist adalimumab. The considerably lower cost of these products h...
Alternative Titles
Full title
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8275172
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8275172
Other Identifiers
ISSN
1177-8881
E-ISSN
1177-8881
DOI
10.2147/DDDT.S317382
